
Opinion|Videos|November 30, 2023
Imaging Scans for Assessing HER2-Positive Breast Cancer Progression and Treatment Response
Author(s)Sara M. Tolaney, MD, MPH
Imaging scans provide an invaluable method of monitoring response to HER2-positive breast cancer treatment; frequency of imaging scans depends on individual patient response, symptoms, and the need to monitor for side effects such as interstitial lung disease.
Advertisement
Episodes in this series

Advertisement
Advertisement
Advertisement
Trending on CURE
1
FDA Updates Safety Warnings for Common Chemotherapy Drugs
2
KTX-1001 Elicits Responses in Some With Multiple Myeloma
3
FDA Removes Use Limitation for Yescarta in Primary CNS Lymphoma
4
Real-World Data with Amtagvi Show High Response Rates in Advanced Melanoma
5




